Direct Detection of Fluoroquinolone Resistance in Sputum Samples from Tuberculosis Patients by High Resolution Melt Curve Analysis
© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature..
Multidrug-resistant tuberculosis (MDR-TB) requires treatment with fluoroquinolone (FLQ) drugs, however, the excessive use of FLQ has led to the rise of extensively drug-resistant TB. In 2019, ~ 20% of total MDR-TB cases were estimated to be resistant to FLQ drugs. In the present study, we developed and evaluated the utility of high-resolution melt curve analysis (HRM) for the rapid detection of FLQ-resistant Mycobacterium tuberculosis for the first time directly from sputum samples. A reference plasmid library was generated for the most frequently observed mutations of gyrA gene and was used to discriminate between mutant and wild-type samples in the FLQ-HRM assay. The developed assay was evaluated on n = 25 MDR M. tuberculosis clinical isolates followed by validation on archived sputum DNA (n = 88) using DNA sequencing as a gold standard. The FLQ-HRM assay showed a 100% sensitivity [95% Confidence Interval (CI): 71.5 to 100] and specificity (95% CI: 39.7 to 100) in smear-positive category, and a sensitivity of 88.9% (95% CI: 77.3 to 95.8) with 84.2% (95% CI: 60.4 to 96.6) specificity in smear-negative category. The assay showed a high level of concordance of ~ 90% (κ = 0.74) with DNA sequencing, however, we were limited by the absence of phenotypic drug susceptibility testing data. In conclusion, HRM is a rapid, cost-effective (INR 150/USD 1.83) and closed-tube method for direct detection of FLQ resistance in sputum samples including direct smear-negative samples.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:81 |
---|---|
Enthalten in: |
Current microbiology - 81(2023), 1 vom: 02. Dez., Seite 27 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Gupta, Rakesh Kumar [VerfasserIn] |
---|
Links: |
---|
Themen: |
Antitubercular Agents |
---|
Anmerkungen: |
Date Completed 04.12.2023 Date Revised 10.01.2024 published: Electronic Citation Status MEDLINE |
---|
doi: |
10.1007/s00284-023-03519-2 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM365327271 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM365327271 | ||
003 | DE-627 | ||
005 | 20240114233436.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1007/s00284-023-03519-2 |2 doi | |
028 | 5 | 2 | |a pubmed24n1255.xml |
035 | |a (DE-627)NLM365327271 | ||
035 | |a (NLM)38041739 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Gupta, Rakesh Kumar |e verfasserin |4 aut | |
245 | 1 | 0 | |a Direct Detection of Fluoroquinolone Resistance in Sputum Samples from Tuberculosis Patients by High Resolution Melt Curve Analysis |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 04.12.2023 | ||
500 | |a Date Revised 10.01.2024 | ||
500 | |a published: Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature. | ||
520 | |a Multidrug-resistant tuberculosis (MDR-TB) requires treatment with fluoroquinolone (FLQ) drugs, however, the excessive use of FLQ has led to the rise of extensively drug-resistant TB. In 2019, ~ 20% of total MDR-TB cases were estimated to be resistant to FLQ drugs. In the present study, we developed and evaluated the utility of high-resolution melt curve analysis (HRM) for the rapid detection of FLQ-resistant Mycobacterium tuberculosis for the first time directly from sputum samples. A reference plasmid library was generated for the most frequently observed mutations of gyrA gene and was used to discriminate between mutant and wild-type samples in the FLQ-HRM assay. The developed assay was evaluated on n = 25 MDR M. tuberculosis clinical isolates followed by validation on archived sputum DNA (n = 88) using DNA sequencing as a gold standard. The FLQ-HRM assay showed a 100% sensitivity [95% Confidence Interval (CI): 71.5 to 100] and specificity (95% CI: 39.7 to 100) in smear-positive category, and a sensitivity of 88.9% (95% CI: 77.3 to 95.8) with 84.2% (95% CI: 60.4 to 96.6) specificity in smear-negative category. The assay showed a high level of concordance of ~ 90% (κ = 0.74) with DNA sequencing, however, we were limited by the absence of phenotypic drug susceptibility testing data. In conclusion, HRM is a rapid, cost-effective (INR 150/USD 1.83) and closed-tube method for direct detection of FLQ resistance in sputum samples including direct smear-negative samples | ||
650 | 4 | |a Journal Article | |
650 | 7 | |a Antitubercular Agents |2 NLM | |
650 | 7 | |a Isoniazid |2 NLM | |
650 | 7 | |a V83O1VOZ8L |2 NLM | |
650 | 7 | |a Rifampin |2 NLM | |
650 | 7 | |a VJT6J7R4TR |2 NLM | |
650 | 7 | |a Fluoroquinolones |2 NLM | |
700 | 1 | |a Anthwal, Divya |e verfasserin |4 aut | |
700 | 1 | |a Bhalla, Manpreet |e verfasserin |4 aut | |
700 | 1 | |a Tyagi, Jaya Sivaswami |e verfasserin |4 aut | |
700 | 1 | |a Choudhary, Sangeeta |e verfasserin |4 aut | |
700 | 1 | |a Haldar, Sagarika |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Current microbiology |d 1978 |g 81(2023), 1 vom: 02. Dez., Seite 27 |w (DE-627)NLM01260318X |x 1432-0991 |7 nnns |
773 | 1 | 8 | |g volume:81 |g year:2023 |g number:1 |g day:02 |g month:12 |g pages:27 |
856 | 4 | 0 | |u http://dx.doi.org/10.1007/s00284-023-03519-2 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 81 |j 2023 |e 1 |b 02 |c 12 |h 27 |